Advertisement

Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population

  • Maria Papasavva
  • Martha-Spyridoula Katsarou
  • Michail Vikelis
  • Euthymia Mitropoulou
  • Emmanouil V. Dermitzakis
  • Stylianos Papakonstantinou
  • Chryssa Arvaniti
  • Dimos-Dimitrios Mitsikostas
  • Illana Gozes
  • Aristides M. Tsatsakis
  • Nikolaos DrakoulisEmail author
Article
  • 29 Downloads

Abstract

Studies point to an increased hereditary risk of cluster headache. HCRTR2 gene rs2653349 and ADH4 gene rs1800759 polymorphisms have been associated with cluster headache susceptibility. Also, GNB3 rs5443 polymorphism, associated with increased signal transduction via GPCRs, seems to influence triptan treatment response. DNA from 114 cluster headache patients and 570 non-related controls, representing a general Southeastern European Caucasian (SEC) population, was extracted from buccal swabs and genotyped using real-time PCR. Gene distribution for the rs2653349 was GG = 79.8%, GA = 18.4%, and AA = 1.8% for patients and GG = 79.1%, GA = 19.1%, and AA = 1.8% for controls. The frequency of the mutated A allele was 11.0% for patients and 11.3% for controls. The frequencies for rs5443 were CC = 44.7%, CT = 44.7%, and TT = 10.5% for patients and CC = 43.9%, CT = 42.6%, and TT = 13.5% for controls. The frequency of the mutated T allele was 32.9% for patients and 34.8% for controls. A 2.7-fold more frequent appearance of the mutated T allele was observed in patients with better triptan treatment response, although not statistically significant. For rs1800759, the frequencies were CC = 36.0%, CA = 43.0%, and AA = 21.0% for patients and CC = 34.0%, CA = 50.2%, and AA = 15.8% for controls. The frequency of the mutated A allele was 42.5% and 40.9% for patients and controls, respectively. The mutated T allele of GNB3 rs5443 polymorphism was more prevalent in patients with better triptan treatment response, indicating a possible trend of association between this polymorphism and triptan treatment response in SEC population. According to our observation, no association of HCRTR2 rs2653349 and ADH4 rs1800759 polymorphisms and cluster headache in SEC population could be documented.

Keywords

Pharmacogenomics rs2653349 rs5443 rs1800759 Southeastern European Caucasians Genetic susceptibility 

Abbreviations

SEC

Southeastern European Caucasian

CH

Cluster headache

ICHD-III

International Classification of Headache Disorders 3rd edition

TACs

Trigeminal autonomic cephalalgias

ECH

Episodic cluster headache

CCH

Chronic cluster headache

GPCRs

G protein-coupled receptors

ADH

Alcohol dehydrogenase enzyme

HWE

Hardy-Weinberg equilibrium

Notes

Acknowledgments

The authors would like to thank Georgia Kanelopoulos for helping to improve the manuscript.

Compliance with Ethical Standards

The study was approved by the Ethics Committee of Mediterraneo Hospital, Glyfada, Greece and Eginition University Hospital, Athens, Greece. Informed consent was obtained from all subjects.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Anttila S, Kampman O, Illi A, Rontu R, Lehtimäki T, Leinonen E (2007) Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach. BMC Psychiatry 7:22.  https://doi.org/10.1186/1471-244X-7-22 CrossRefPubMedPubMedCentralGoogle Scholar
  2. Banaś A, Płońska E, Larysz B et al (2012) Influence of 825 C>T polymorphism of G protein β3 subunit gene (GNB3) on hemodynamic response during dobutamine stress echocardiography. Pharmacol Rep 64:123–128.  https://doi.org/10.1016/S1734-1140(12)70738-7 CrossRefPubMedGoogle Scholar
  3. Baumber L, Sjostrand C, Leone M et al (2006) A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology 66:1888–1893.  https://doi.org/10.1212/01.wnl.0000219765.95038.d7 CrossRefPubMedGoogle Scholar
  4. Cederbaum AI (2012) Alcohol metabolism. Clin Liver Dis 16:667–685.  https://doi.org/10.1016/j.cld.2012.08.002 CrossRefPubMedPubMedCentralGoogle Scholar
  5. Chieffi S, Carotenuto M, Monda V, Valenzano A, Villano I, Precenzano F, Tafuri D, Salerno M, Filippi N, Nuccio F, Ruberto M, de Luca V, Cipolloni L, Cibelli G, Mollica MP, Iacono D, Nigro E, Monda M, Messina G, Messina A (2017) Orexin system: the key for a healthy life. Front Physiol 8:357.  https://doi.org/10.3389/fphys.2017.00357 CrossRefPubMedPubMedCentralGoogle Scholar
  6. Chiou L-C, Lee H-J, Ho Y-C et al (2010) Orexins/hypocretins: pain regulation and cellular actions. Curr Pharm Des 16:3089–3100. doi.  https://doi.org/10.2174/138161210793292483 CrossRefGoogle Scholar
  7. Costa A, Antonaci F, Ramusino M, Nappi G (2015) The neuropharmacology of cluster headache and other trigeminal autonomic cephalalgias. Curr Neuropharmacol 13:304–323.  https://doi.org/10.2174/1570159X13666150309233556 CrossRefPubMedPubMedCentralGoogle Scholar
  8. Durham PL, Vause CV (2010) Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs 24:539–548.  https://doi.org/10.2165/11534920-000000000-00000 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Edenberg HJ (2007) The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 30:5–13PubMedPubMedCentralGoogle Scholar
  10. Fan Z, Hou L, Wan D, Ao R, Zhao D, Yu S (2018) Genetic association of HCRTR2, ADH4 and CLOCK genes with cluster headache: a Chinese population-based case-control study. J Headache Pain 19:1.  https://doi.org/10.1186/s10194-017-0831-1 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Fischera M, Marziniak M, Gralow I, Evers S (2008) The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia 28:614–618.  https://doi.org/10.1111/j.1468-2982.2008.01592.x CrossRefPubMedGoogle Scholar
  12. Flores Á, Maldonado R, Berrendero F (2013) Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci 7:256.  https://doi.org/10.3389/fnins.2013.00256 CrossRefPubMedPubMedCentralGoogle Scholar
  13. Fourier C, Ran C, Steinberg A, Sjöstrand C, Waldenlind E, Belin AC (2019) Analysis of HCRTR2 gene variants and cluster headache in Sweden. Headache J Head Face Pain 59:410–417.  https://doi.org/10.1111/head.13462 CrossRefGoogle Scholar
  14. Fourier C, Ran C, Steinberg A, Sjöstrand C, Waldenlind E, Carmine Belin A (2016) Screening of two ADH4 variations in a Swedish cluster headache case-control material. Headache J Head Face Pain 56:835–840.  https://doi.org/10.1111/head.12807 CrossRefGoogle Scholar
  15. Goadsby PJ (2002) Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 1:251–257.  https://doi.org/10.1016/s1474-4422(02)00104-7 CrossRefPubMedGoogle Scholar
  16. Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache neuropeptide changes and effects of acute attacks therapies. Brain 117:427–434.  https://doi.org/10.1093/brain/117.3.427 CrossRefPubMedGoogle Scholar
  17. Guo L, Zhang L-L, Zheng B, Liu Y, Cao XJ, Pi Y, Li BH, Li JC (2013) The C825T Polymorphism of the G-Protein β3 subunit gene and its association with hypertension and stroke: an updated meta-analysis. PLoS One 8:e65863.  https://doi.org/10.1371/journal.pone.0065863 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211.  https://doi.org/10.1177/0333102417738202 CrossRefGoogle Scholar
  19. Katsarou M-S, Latsi R, Papasavva M et al (2016) Population-based analysis of the frequency of HFE gene polymorphisms: correlation with the susceptibility to develop hereditary hemochromatosis. Mol Med Rep:14.  https://doi.org/10.3892/mmr.2016.5317 CrossRefGoogle Scholar
  20. Katsarou M-S, Papasavva M, Latsi R, Toliza I, Gkaros AP, Papakonstantinou S, Gatzonis S, Mitsikostas DD, Kovatsi L, Izotov BN, Tsatsakis AM, Drakoulis N (2018) Population-based analysis of cluster headache-associated genetic polymorphisms. J Mol Neurosci 65:367–376.  https://doi.org/10.1007/s12031-018-1103-5 CrossRefPubMedGoogle Scholar
  21. Katsarou M, Giakoumaki M, Papadimitriou A, Demertzis N, Androutsopoulos V, Drakoulis N (2017a) Genetically driven antioxidant capacity in a Caucasian Southeastern European population. Mech Ageing Dev 172:1–5.  https://doi.org/10.1016/j.mad.2017.08.010 CrossRefPubMedGoogle Scholar
  22. Katsarou M, Karakonstantis K, Demertzis N et al (2017b) Effect of single-nucleotide polymorphisms in ADH1B , ADH4 , ADH1C , OPRM1 , DRD2 , BDNF , and ALDH2 genes on alcohol dependence in a Caucasian population. Pharmacol Res Perspect 5:e00326.  https://doi.org/10.1002/prp2.326 CrossRefPubMedCentralGoogle Scholar
  23. Klenke S, Kussmann M, Siffert W (2011) The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics 21:594–606.  https://doi.org/10.1097/FPC.0b013e3283491153 CrossRefPubMedGoogle Scholar
  24. Láinez MJA, Guillamón E (2017) Cluster headache and other TACs: pathophysiology and neurostimulation options. Headache J Head Face Pain 57:327–335.  https://doi.org/10.1111/head.12874 CrossRefGoogle Scholar
  25. Leone M, Proietti Cecchini A (2017) Advances in the understanding of cluster headache. Expert Rev Neurother 17:165–172.  https://doi.org/10.1080/14737175.2016.1216796 CrossRefPubMedGoogle Scholar
  26. Luo X, Kranzler HR, Zuo L, Lappalainen J, Yang BZ, Gelernter J (2006) ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case–control association studies. Neuropsychopharmacology 31:1085–1095.  https://doi.org/10.1038/sj.npp.1300925 CrossRefPubMedGoogle Scholar
  27. May A (2005) Cluster headache: pathogenesis, diagnosis, and management. Lancet 366:843–855.  https://doi.org/10.1016/S0140-6736(05)67217-0 CrossRefPubMedGoogle Scholar
  28. Morrison AC, Doris PA, Folsom AR et al (2001) G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 32:822–9. doi.  https://doi.org/10.1161/01.STR.32.4.822 CrossRefGoogle Scholar
  29. Nejatizadeh A, Kumar R, Stobdanand T, Pasha MQ (2011) Association of GNB3 C825T polymorphism with plasma electrolyte balance and susceptibility to hypertension. Genet Mol Biol 34:553–556.  https://doi.org/10.1590/S1415-47572011005000052 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Pinessi L, Rainero I, Rivoiro C, Rubino E, Gallone S (2005) Genetics of cluster headache: an update. J Headache Pain 6:234–236.  https://doi.org/10.1007/s10194-005-0194-x CrossRefPubMedPubMedCentralGoogle Scholar
  31. Rainero I, Gallone S, Rubino E et al (2008a) Haplotype analysis confirms the association between the HCRTR2 gene and cluster headache. Headache J Head Face Pain 48:1108–1114.  https://doi.org/10.1111/j.1526-4610.2008.01080.x CrossRefGoogle Scholar
  32. Rainero I, Gallone S, Valfre W et al (2004) A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology 63:1286–1288.  https://doi.org/10.1212/01.WNL.0000142424.65251.DB CrossRefPubMedGoogle Scholar
  33. Rainero I, De Martino P, Pinessi L (2008b) Hypocretins and primary headaches: neurobiology and clinical implications. Expert Rev Neurother 8:409–416.  https://doi.org/10.1586/14737175.8.3.409 CrossRefPubMedGoogle Scholar
  34. Rainero I, Rubino E, Gallone S, et al. (2010) Cluster headache is associated with the alcohol dehydrogenase 4 ( ADH4 ) gene. Headache J Head Face Pain 50:92–98.  https://doi.org/10.1111/j.1526-4610.2009.01569.x CrossRefGoogle Scholar
  35. Rainero I, Rubino E, Valfrè W, Gallone S, de Martino P, Zampella E, Pinessi L (2007) Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis. J Headache Pain 8:152–156.  https://doi.org/10.1007/s10194-007-0383-x CrossRefPubMedPubMedCentralGoogle Scholar
  36. Ran C, Fourier C, Michalska JM, Steinberg A, Sjöstrand C, Waldenlind E, Belin AC (2017) Screening of genetic variants in ADCYAP1R1, MME and 14q21 in a Swedish cluster headache cohort. J Headache Pain 18:88.  https://doi.org/10.1186/s10194-017-0798-y CrossRefPubMedPubMedCentralGoogle Scholar
  37. Razavi BM, Hosseinzadeh H (2017) A review of the role of orexin system in pain modulation. Biomed Pharmacother 90:187–193.  https://doi.org/10.1016/j.biopha.2017.03.053 CrossRefPubMedGoogle Scholar
  38. Rodriguez S, Gaunt TR, Day INM (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505–514.  https://doi.org/10.1093/aje/kwn359 CrossRefPubMedPubMedCentralGoogle Scholar
  39. Schürks M (2010) Genetics of cluster headache. Curr Pain Headache Rep 14:132–139.  https://doi.org/10.1007/s11916-010-0096-8 CrossRefPubMedGoogle Scholar
  40. Schurks M, Kurth T, Geissler I et al (2006) Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology 66:1917–1919.  https://doi.org/10.1212/01.wnl.0000215852.35329.34 CrossRefPubMedGoogle Scholar
  41. Schürks M, Kurth T, Knorn P, Pageler L, Diener HC (2006) Predictors of hazardous alcohol consumption among patients with cluster headache. Cephalalgia 26:623–627.  https://doi.org/10.1111/j.1468-2982.2006.01079.x CrossRefPubMedGoogle Scholar
  42. Schürks M, Kurth T, Stude P, Rimmbach C, de Jesus J, Jonjic M, Diener HC, Rosskopf D (2007) G Protein β3 polymorphism and triptan response in cluster headache. Clin Pharmacol Ther 82:396–401.  https://doi.org/10.1038/sj.clpt.6100159 CrossRefPubMedGoogle Scholar
  43. Semplicini A (2001) G protein β3 subunit gene 825T allele is associated with increased left ventricular mass in young subjects with mild hypertension. Am J Hypertens 14:1191–1195.  https://doi.org/10.1016/S0895-7061(01)02227-0 CrossRefPubMedGoogle Scholar
  44. Siffert W (2003) Effects of the G protein β3-subunit gene C825T polymorphism: should hypotheses regarding the molecular mechanisms underlying enhanced G protein activation be revised? Focus on A splice variant of the G protein β3-subunit implicated in disease states does. Physiol Genomics 13:81–84.  https://doi.org/10.1152/physiolgenomics.00031.2003 CrossRefPubMedGoogle Scholar
  45. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B (1998) Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 18:45–48.  https://doi.org/10.1038/ng0198-45 CrossRefPubMedGoogle Scholar
  46. Sjaastad O, Bakketeig L (2003) Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia 23:528–533.  https://doi.org/10.1046/j.1468-2982.2003.00585.x CrossRefPubMedGoogle Scholar
  47. Sjöstrand C (2009) Genetic aspects of cluster headache. Expert Rev Neurother 9:359–368.  https://doi.org/10.1586/14737175.9.3.359 CrossRefPubMedGoogle Scholar
  48. Sun Z, Runne C, Tang X, Lin F, Chen S (2012) The Gβ3 splice variant associated with the C825T gene polymorphism is an unstable and functionally inactive protein. Cell Signal 24:2349–2359.  https://doi.org/10.1016/j.cellsig.2012.08.011 CrossRefPubMedPubMedCentralGoogle Scholar
  49. Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP (2014) OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Front Neurosci 8:57.  https://doi.org/10.3389/fnins.2014.00057 CrossRefPubMedPubMedCentralGoogle Scholar
  50. Thompson MD, Sakurai T, Rainero I, Maj MCKJ (2017) Orexin receptor multimerization versus functional interactions: neuropharmacological implications for opioid and cannabinoid signalling and pharmacogenetics. Pharmaceuticals 10:79.  https://doi.org/10.3390/ph10040079 CrossRefGoogle Scholar
  51. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E (2001) C825T Polymorphism of the G Protein β 3 -subunit and antihypertensive response to a thiazide diuretic. Hypertension 37:739–743.  https://doi.org/10.1161/01.HYP.37.2.739 CrossRefPubMedGoogle Scholar
  52. Vikelis M, Rapoport AM (2016) Cluster headache in Greece: an observational clinical and demographic study of 302 patients. J Headache Pain 17:88.  https://doi.org/10.1186/s10194-016-0683-0 CrossRefPubMedPubMedCentralGoogle Scholar
  53. Weller CM, Wilbrink LA, Houwing-Duistermaat JJ, Koelewijn SC, Vijfhuizen LS, Haan J, Ferrari MD, Terwindt GM, van den Maagdenberg A, de Vries B (2015) Cluster headache and the hypocretin receptor 2 reconsidered: a genetic association study and meta-analysis. Cephalalgia 35:741–747.  https://doi.org/10.1177/0333102414557839 CrossRefPubMedGoogle Scholar
  54. Zarrilli F, Tomaiuolo R, Ceglia C, Lombardo B, Izzo B, Castaldo G, Pastore L, de Simone R (2015) Molecular analysis of cluster headache. Clin J Pain 31:52–57.  https://doi.org/10.1097/AJP.0000000000000075 CrossRefPubMedGoogle Scholar
  55. Zha Z, Han X-R, Smith MD, Lei QY, Guan KL, Xiong Y (2016) Hypertension-associated C825T polymorphism impairs the function of Gβ3 to target GRK2 ubiquitination. Cell Discov 2:16005.  https://doi.org/10.1038/celldisc.2016.5 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Maria Papasavva
    • 1
  • Martha-Spyridoula Katsarou
    • 1
  • Michail Vikelis
    • 2
  • Euthymia Mitropoulou
    • 3
  • Emmanouil V. Dermitzakis
    • 4
  • Stylianos Papakonstantinou
    • 1
  • Chryssa Arvaniti
    • 5
  • Dimos-Dimitrios Mitsikostas
    • 3
  • Illana Gozes
    • 6
  • Aristides M. Tsatsakis
    • 7
  • Nikolaos Drakoulis
    • 1
    Email author
  1. 1.Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health SciencesNational and Kapodistrian University of AthensAthensGreece
  2. 2.Headache ClinicMediterraneo HospitalGlyfadaGreece
  3. 3.First Department of Neurology, Eginition Hospital, School of MedicineNational and Kapodistrian University of AthensAthensGreece
  4. 4.ThessalonikiGreece
  5. 5.B’ Neurological Clinic, Attikon Hospital, School of MedicineNational and Kapodistrian University of AthensAthensGreece
  6. 6.The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine Sagol School of Neuroscience and Adams Super Center for Brain StudiesTel Aviv UniversityTel AvivIsrael
  7. 7.Laboratory of Toxicology, School of MedicineUniversity of CreteHeraklionGreece

Personalised recommendations